×
Hero Background

Anti Viral Drugs Companies

ID: MRFR/HC/1821-HCR
200 Pages
Rahul Gotadki
October 2025

Anti-viral drugs are designed to treat viral infections by inhibiting the replication of viruses.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Anti-Viral Drugs Market Research Report- Forecast to 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Anti Viral Drugs Market

Anti-viral drugs Key Companies

 

Latest Anti-viral drugs Companies Update


Pfizer's Paxlovid transition to commercial distribution: November 2023, Pfizer's oral COVID-19 treatment Paxlovid transitioned from government-managed distribution to traditional commercial channels. This move aims to improve patient access and availability beyond government supply.


Gilead Sciences receives FDA approval for Sunvepra for cytomegalovirus (CMV) infections: September 2023, Gilead Sciences received FDA approval for Sunvepra (ciluprevvir/ganciclovir) for the treatment of CMV infections in adult hematopoietic stem cell transplant recipients.


Roche secures positive Phase 3 trial results for Actemra/RoActemra combination in preventing CMV disease: October 2023, Roche announced positive results from a Phase 3 trial evaluating the combination of Actemra/RoActemra (tocilizumab) with standard-of-care anti-viral therapy for preventing CMV disease in adult kidney transplant recipients.


List of Anti-viral drugs Key Companies in the Market



  • Johnson & Johnson

  • Merck & Co. Inc.

  • Gilead Sciences Inc.

  • Hoffmann-La Roche Ltd.

  • GlaxoSmithKline Plc

  • Abbott Laboratories

  • Novartis International AG

  • Astra Zeneca AB

  • Cipla Inc.